Amber Therapeutics’ $100 Million Series A Financing Round

Wilson Sonsini Goodrich & Rosati advised Amber on the transaction.Amber Therapeutics, a UK-based medical technology company, announced it closed a Series A financing, raising $100 million…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here